URAC Specialty Pharmacy Services Accreditation — Frequently Asked Questions

What is URAC Specialty Pharmacy Services Accreditation?

URAC Specialty Pharmacy Services Accreditation is a three-year quality credential from URAC — the Utilization Review Accreditation Commission — recognizing organizations that provide support service functions for licensed specialty pharmacy partners. The program is designed for hub services organizations, patient support programs, specialty pharmacy support centers, and similar entities whose primary function is coordinating patient services, communication, benefits support, and quality management on behalf of specialty pharmacy partners — without directly dispensing specialty medications to patients.

URAC built this credential to recognize that high-quality specialty pharmacy care depends not only on the dispensing pharmacy but on the infrastructure of support services surrounding the patient: benefits investigations, prior authorizations, patient education, adherence monitoring, and clinical coordination. This program validates that infrastructure.

How does URAC Specialty Pharmacy Services Accreditation differ from URAC Specialty Pharmacy Accreditation?

These are two structurally distinct URAC programs targeting different organizational types. The threshold question is: does your organization dispense specialty medications directly to patients?

• URAC Specialty Pharmacy Accreditation — for licensed pharmacies that dispense specialty medications to patients and provide patient management services. Standards cover pharmacy operations, medication distribution, patient management, performance monitoring, and require measures reporting to URAC.
• URAC Specialty Pharmacy Services Accreditation — for organizations providing support functions to licensed specialty pharmacy partners without directly dispensing. Standards focus on patient service quality, communication, quality management, consumer protection, and risk management. No performance measures reporting to URAC required.

Misidentifying which program applies wastes documentation investment and resets timelines. IHS conducts program navigator analysis before any documentation work begins.

Who is eligible for URAC Specialty Pharmacy Services Accreditation?

Organizations that provide support service functions for licensed specialty pharmacy partners and operate in the United States. Eligible types include:

• Hub services organizations (HSOs) managing patient access, benefits investigations, and prior authorization support
• Specialty pharmacy support centers providing patient communication and adherence services
• Pharmaceutical manufacturer patient support programs for specific specialty therapeutic areas
• Specialty distribution support organizations involved in limited distribution drug logistics coordination
• Integrated health system specialty pharmacy support functions
• Third-party patient services vendors contracted to specialty pharmacy networks

Licensed pharmacies that directly dispense specialty medications to patients are not eligible. They must pursue URAC Specialty Pharmacy Accreditation.

Does Specialty Pharmacy Services Accreditation require performance measures reporting?

No. Unlike URAC Specialty Pharmacy Accreditation, this credential does not require performance measures reporting to URAC. The accreditation evaluates patient service quality, communication protocols, quality management infrastructure, consumer protection processes, and risk management — operational domains appropriate to support organizations rather than the clinical dispensing performance metrics tracked under the full pharmacy program.

What standards does URAC Specialty Pharmacy Services Accreditation cover?

Standards address the operational domains most relevant to support organizations:

• Patient Service and Communication — protocols for patient outreach, education delivery, and documentation of communication activities
• Quality Management and Improvement — documented quality management system with defined metrics, monitoring processes, and improvement cycles
• Risk Management — ongoing operational risk analysis, mitigation strategies, and regulatory monitoring processes
• Consumer Protection and Empowerment — patient grievance and appeals processes with defined timeframes, escalation pathways, and patient rights disclosures
• Operations and Infrastructure — organizational governance, personnel qualifications, and training documentation
• Regulatory Compliance Monitoring — documented processes for tracking regulatory changes and implementing operational responses

Complete standards are available through the URAC store. IHS provides standards interpretation as part of every engagement.

How long does URAC Specialty Pharmacy Services Accreditation take?

URAC states that organizations can achieve accreditation in six months or less from formal application. This is achievable for organizations that complete pre-application gap analysis and documentation development before submitting. Organizations that begin the formal URAC process without pre-existing compliant documentation typically encounter extended desktop review cycles with multiple RFI iterations, pushing total elapsed time well beyond six months.

IHS engages before the application is submitted — completing gap analysis and documentation development first — to support the six-month timeline URAC describes.

What is the URAC Specialty Pharmacy Services accreditation process?

1. Eligibility confirmation — verify the organization qualifies as a support service organization, not a licensed dispensing pharmacy
2. Standards acquisition — obtain URAC Specialty Pharmacy Services standards from the URAC store
3. Application submission — submit the application agreement to URAC
4. Documentation development and upload — develop and upload required policies, procedures, and operational documentation
5. Desktop review — URAC reviews submitted materials; RFIs issued for identified deficiencies
6. Validation review — on-site or remote review including staff interviews and operational validation
7. Committee decision — URAC Accreditation Committee issues accreditation decision
8. Corrective action (if needed) — organizations address post-review findings before final award

Three-year accreditation is valid from the award date. Mid-cycle compliance checks may occur with approximately 14 days' notice.

What is a hub services organization and does it need URAC accreditation?

A hub services organization (HSO) manages patient access services for specialty medications on behalf of pharmaceutical manufacturers or specialty pharmacy networks — including benefits investigations, prior authorization support, copay assistance enrollment, patient assistance program administration, and clinical case management coordination. HSOs do not dispense medications.

URAC Specialty Pharmacy Services Accreditation is designed precisely for this organizational model. Whether an HSO needs the accreditation depends on market positioning. The credential is currently voluntary, but pharmaceutical manufacturers and specialty pharmacy networks are increasingly evaluating quality credentials when selecting hub services partners. IHS advises on whether accreditation aligns with your specific market and contract strategy.

Is URAC Specialty Pharmacy Services Accreditation required by payers or manufacturers?

The accreditation is currently voluntary. No payer or manufacturer has established it as a universal contractual requirement. However, the specialty pharmacy support services market is evolving — quality credentials are an increasing differentiator in hub services contracting and manufacturer patient support program partnerships. Organizations holding this accreditation can demonstrate independently validated quality in a market where quality differentiation among support organizations is otherwise difficult for buyers to assess.

IHS advises on whether accreditation aligns with your contract portfolio and market strategy before recommending it as a priority investment.

What are the most common documentation gaps in Specialty Pharmacy Services applications?

1. Absence of a formal quality management system — most support organizations have informal monitoring practices that do not satisfy URAC's structured documentation requirements
2. Incomplete consumer grievance and appeals procedures — informal complaint handling without documented timeframes, escalation pathways, and patient rights disclosures
3. Risk management treated as a one-time assessment rather than an ongoing documented process with defined monitoring frequency and response protocols
4. Inconsistent personnel qualification and training documentation across staff categories, particularly in organizations that have grown through hub services contract expansion
5. Regulatory monitoring without a documented process — awareness of the regulatory environment without defined responsibility, frequency, or documented response procedures

IHS identifies all gaps before application and resolves them during documentation development, preventing RFI cycles that extend the timeline.

Can a support organization and its licensed pharmacy partner both hold URAC accreditation simultaneously?

Yes. A hub services organization can hold URAC Specialty Pharmacy Services Accreditation while its licensed pharmacy partner holds URAC Specialty Pharmacy Accreditation — these are separate credentials covering different organizational entities. For integrated health systems with both a specialty pharmacy dispensing operation and a support services division, this dual-accreditation structure demonstrates quality across the full patient care continuum.

IHS coordinates documentation strategies across both programs when a client's engagement involves this structure, identifying documentation that satisfies requirements under both standards sets to minimize redundant work.

How much does URAC Specialty Pharmacy Services Accreditation cost?

URAC fees for Specialty Pharmacy Services Accreditation are set by URAC and should be verified directly at urac.org, as URAC adjusts fees periodically. IHS consulting fees are scoped per engagement based on your organization's size, current documentation state, and operational complexity — contact IHS for a tailored proposal.

What happens during the URAC validation review?

URAC's validation review involves URAC staff reviewing the organization's operations through staff interviews, documentation review, and validation of documented processes against actual operational practice. The review may be conducted on-site or remotely. URAC generates a compliance score based on review findings.

Organizations whose staff understand — not just possess — their documented processes perform best in validation reviews. IHS prepares staff through pre-review preparation sessions covering common surveyor inquiry areas and documentation retrieval protocols.

How does IHS support clients after accreditation is awarded?

IHS provides ongoing post-award support throughout the three-year accreditation cycle: responding to URAC mid-cycle compliance check inquiries (which may arrive with approximately 14 days' notice); updating documentation when regulatory changes affect applicable standards; supporting quality management system maintenance; and preparing organizations for re-accreditation before the three-year term concludes. Maintaining accreditation requires operational discipline throughout the cycle, not just at the award date.

Why work with IHS rather than pursue URAC accreditation independently?

Organizations that pursue URAC accreditation without consulting support most commonly encounter two costly outcomes: extended desktop review cycles due to documentation gaps identified by the URAC reviewer after submission, and validation review findings that require corrective action before accreditation is awarded. Both outcomes extend the total timeline and increase internal resource burden.

IHS resolves documentation gaps before submission, manages the entire RFI cycle, and prepares staff for the validation review — compressing the timeline and reducing internal burden. IHS is led by Thomas G. Goddard, JD, PhD — former Chief Operating Officer and General Counsel of URAC — bringing direct institutional knowledge of how URAC's pharmacy programs are structured and reviewed.